Analysis of clinical and psychological risk factors and frequency-quantitative characteristics of substance abuse in patients with alcohol and substances use disorders (Part 1)
|
Full Text:
Subscribers Only
|
Suggested citation:
Fadeeva EV. [Analysis of clinical and psychological risk factors and frequency-quantitative characteristics of substance abuse in patients with alcohol and substances use disorders (Part 1)]. Rossiiskii psikhiatricheskii zhurnal [Russian Journal of Psychiatry]. 2024;(6):80-91. Russian
This cohort study involved 339 patients: 232 men and 107 women with alcohol or substances use disorders. To study the psycho-emotional and personality predictors of substance abuse, the K-10 and IES-R scales and the MGAA addictive attitudes test were used. To assess the frequency and quantitative characteristics of psychoactive substance use, the AUDIT-C and ASSIST screening tests were used, and CDT was selectively determined. Psychological distress symptoms were identified in 48.7% of the patients, and PTSD symptoms of varying severity were found in 25.7%, usually at the level of its severe manifestations and typically observed in women. According to the total score of the AUDIT-C and ASSIST tests, significant gender differences were revealed – the highest scores were observed among men with problematic alcohol use (p≤0.001). The assessment of the level of risk associated with drug use according to the ASSIST test showed that the 2.3% of patients who abuse alcohol had a high risk of drug abuse, indicating the presence of possible comorbidity with respect to these types of substances use disorders.
Keywords tobacco; alcohol; drugs; sedatives and hypnotics; problematic use; substance abuse; substance abuse disorders; women; men
1. GBD 2020 Alcohol Collaborators. Population-level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis for the Global Burden of Disease Study 2020. Lancet. 2022;400(10347):185–235. DOI: 10.1016/S0140- 6736(22)00847-9 2. Shport SV, Klimenko TV, Shmukler AB, et al. [Increasing the efficiency of addiction medical treatment as a factor in reducing mortality and increasing life expectancy in the Russian Federation]. Rossiiskii psikhiatricheskii zhurnal [Russian Journal of Psychiatry]. 2024;(1):4–15. (In Russ.) 3. Utkin SI. Rasstrojstva vsledstvie upotrebleniya alkogolya. Narkologiya: nacional`noe rukovodstvo. NN Ivanecz, MA Vinnikova, editors. Moscow: GE`OTAR-Media; 2024. р. 261–77. (In Russ.) DOI: 10.33029/ 9704-8363-3-NNG-2024-1-848 4. World Drug Report 2024. United Nations Office on Drugs and Crime (UNODC). United Nations publication. 2024. World Drug Report 2024. URL: https://www.unodc.org/unodc/data-and-analysis/world-drug-report-2024.html (accessed on: 25.09.2024). 5. Mezhdunarodnaya klassifikaciya boleznej 10 peresmotra (MKB-10). (In Russ.) URL: https://mkb-10.com (accessed on: 25.09.2024). 6. Klimenko TV, Korchagina GA, Fadeeva EV, Vyshinsky KV. [Design and methodology of studying the impact of the COVID-19 pandemic on patterns of psychoactive substance use]. Voprosy narkologii [Issues of Narcology]. 2021;2(197):74–99. (In Russ.) DOI: 10.47877/0234-0623_2021_02_74 7. Andrews G, Slade T. Interpreting scores on the Kessler Psychological Distress Scale (K10). Aust N Z J Public Health. 2001;25(6):494–7. DOI: 10.1111/j.1467-842x.2001.tb00310.x 8. Kessler RC, Andrews G, Colpe LJ, et al. Short screening scales to monitor population prevalences and trends in non-specific psychological distress. Psychol Med. 2002;32(6):959–76. DOI: 10.1017/S0033291702006074 9. Horowitz MJ, Wilner M, Alverez W. Impact of Events Scale: A measure of subjective stress. Psychosom Med. 1979;41(3):209–18. DOI: 10.1097/00006842-197905000-00004 10. Tarabrina NV. Praktikum po psixologii posttravmaticheskogo stressa. SPb.: Piter; 2001. 268 р. (In Russ.) 11. MakMallin R. Praktikum po kognitivnoj terapii. SPb.: Rech`; 2001. 560 р. (In Russ.) 12. Abakumova AA, Agibalova TV, Adamova TV, et al. Narkologiya: nacional`noe rukovodstvo. NN Ivanecza, IP Anoxina, MA Vinnikova, editors. Moscow: GE`OTAR-Media; 2016. 944 р. (In Russ.) 13. Korchagina GA, Fadeeva EV, Kolpakov YaV, Grigor`eva AA. Protokoly` mediko-psixologicheskoj korrekcii grupp riska po razvitiyu narkologicheskix zabolevanij. In: Materialy` Vserossijskoj nauchno-prakticheskoj konferencii s mezhdunarodny`m uchastiem “Psixiatriya na e`tapax reform: problemy` i perspektivy`”. NG Neznanov, editor. Moscow: Al`ta Astra; 2015. 398 p. (In Russ.) 14. Brjun EA, Koporov SG, Buzik OZh. Profilaktika narkologicheskix rasstrojstv: Nacional`noe rukovodstvo. EA Bryun, SG Koporov, OZh Buzik, editors. Moscow: N`yu Terra; 2018. 638 р. (In Russ.) 15. Drapkina OM, Kontsevaya AV, Kalinina AM, et al. Profilaktika khronicheskikh neinfektsionnykh zabolevanii v Rossiiskoi Federatsii. Natsional'noe rukovodstvo 2022. Kardiovaskulyarnaya terapiya i profilaktika. 2022;21(4):5–232. (In Russ.) DOI: 10.15829/1728-8800-2022-3235 16. McNeely J, Strauss S, Wright S, et al. Test-retest reliability of a self-administered Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) in primary care patients. J Subst Abuse Treat. 2014;47(1):93–101. DOI: 10.1016/j.jsat.2014.01.007 17. The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): manual for use in primary care. Prepared by R Humeniuk, et al. World Health Organization. 2010. URL: http:.apps.who.int/iris/bitstream/handle/10665/44320/9789241599382_eng.pdf;jsessionid=F43A89F683B471066E0B754A9244AD08?sequence=1 (accessed on: 25.09.2024). 18. Nenast`eva AYu. Metody` diagnostiki upotrebleniya psixoaktivny`x veshhestv. In: Narkologiya: nacional`noe rukovodstvo. NN Ivanecz, MA Vinnikova, editors. Mosсow: GE`OTAR-Media; 2024. р. 760–95. (In Russ.) DOI: 10.33029/ 9704-8363-3-NNG-2024-1-848
Article Metrics
Metrics powered by PLOS ALM